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A B S T R A C T
An overexpression of cell adhesion molecules (CAMs) on the surface of endothelial cells is one of the first steps in a
high glucose-mediated endothelial dysfunction in diabetic patients. The effect of insulin administration in the condition
of elevated glucose concentration on the E-selectin, intracellular adhesion molecule-1 (ICAM-1) and vascular adhesion
molecule-1 (VCAM-1) expression on human aortic endothelial cells (HAEC) was investigated. Cells were cultured for 4h
in a medium supplemented with homocysteine (7 mM) and different concentration of glucose (5.5, 8.0, 12.0 and 16.5 mM
respectively) with or without insulin (1 mIU/mL) addition. Expression of CAMs was analysed by flow-cytometry using
monoclonal antibodies. Controls were CAMs expression in the medium with a corresponding glucose concentration. Ob-
tained results show that short-term exposure of HAECs to moderate high glucose concentrations results in increased ex-
pression of E-selectin (2-fold), VCAM-1 (3-fold) and ICAM-1 (47%). At the same time, HAEC grown with 12 mM glucose
expressed lesser E-selectin and, more ICAM-1 (for 64%) and VCAM-1 (41%) molecules. 16.5 mM glucose decreased ex-
pression of all investigated adhesion molecules. Addition of insulin was not changed expression of CAMs in a medium
with 5.5 mM glucose. In conditions of elevated glucose concentration (12 mM), addition of insulin significantly dropped
E-selectin (27%) and increased VCAM-1 (23%) expression. In conclusion, moderate elevated glucose concentration in-
creased expression of cell adhesion molecules on HAEC. Insulin administration in the mild hyperglycaemia reduces an
expression of the proinflammatory adhesion molecule E-selectin which could contribute in deceleration of macrovascular
complications development in diabetic patients.
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Introduction
Insulin is a powerful anabolic hormone in a wide use
as an anti-diabetic drug for the treatment of diabetes
mellitus type 1 and type 21–4. Results of numbers of stud-
ies show that the risk of developing of cardiovascular dis-
ease as well as risk of cardiovascular events, such as myo-
cardial infarction and stroke, in the type 2 diabetic
patients is being two to four times higher than in healthy
subjects5–8. A majority of studies, performed on human
beings, has shown that hyperinsulinemia results in an
increase of cardio-vascular disease in patient with type 2
diabetes9,10. An association of hyperinsulinemia with in-
creased coronary events in several epidemiological stud-
ies led to the hypothesis that insulin may be athero-
genic11–13. On the other hand, it has been shown that in-
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sulin has a potent vasodilatory effect in vivo on the
arterial and the venous system14,15, but the mechanism of
its action in the vascular wall is still unclear.
Specific molecular interactions of cell adhesion mole-
cules (CAMs) are exceptionally important in a whole va-
riety of processes such as embryogenesis, organogenesis
and neural system development, vascular and epithelial
homeostasis, haemostasis, immune response and infla-
mmation16,17. Expression of E- and P-selectin, vascular
adhesion molecule-1 (VCAM-1), and intracellular adhe-
sion molecule-1 and -2 (ICAM-1, ICAM-2) on the surface
of endothelial cells mediates the interaction between
blood cells and endothelium. The loss of CAMs adhesive
capability and their redundant expression may lead to
leukocyte adhesion deficiency and atherosclerotic cardio-
vascular diseases18–22.
Significant changes in the expression of soluble cell
adhesion molecules (sE-selectin, sICAM-1 and sVCAM-1)
are found in the serum of patients with type 2 dia-
betes23–25. Although cell adhesion molecules expression
on macrovascular endothelial cells may correlate with
their soluble levels, this is not clearly established. Ryysy
and Yki-Järvinen26 have reported that decrease in solu-
ble E-selectin is apparently dependent on improvement
in glycaemia, which suggests that insulin effects could be
indirect through better control of glucose.
As the cell surface expression of CAMs on macro-
vascular endothelial cells can only be studied in vitro,
HAEC and HUVEC cell culture represents optimal mo-
del for such studies. Numbers of studies shown that hu-
man umbilical vein and human aortic endothelial cells,
cultivated in elevated glucose concentration, increase
CAMs expression27,28 which additionally rise if cells are
stimulated with tumour necrosis factor-a (TNF-a)25,29,30.
Studies of Aljada et al. showed that insulin increases en-
dothelial NOS (e-NOS) expression in HAEC, exerts an
anti-inflammatory effect at the endothelial cell level by
reducing the expression of intracellular adhesion mole-
cule-1 (ICAM-1), monocyte chemoattractant protein-1
(MCP-1), and the pro-inflammatory transcription factor,
nuclear factor-kB31,32.
Although several studies have shown that insulin has
a potential to reduce inflammatory response, it remains
unclear whether treatment by insulin could help in the
reduction of incidence or progression of macrovascular
diseases by diminishing expression of CAMs. Therefore,
the aim of the present study was to investigate effects of
elevated glucose concentration and insulin administra-
tion in condition of increased glucose on E-selectin,
ICAM-1 and VCAM-1 expression on human aortic endo-
thelial cells in vitro.
Materials and Methods
Cell culture
Human aortic endothelial cells – HAEC (Cascade
BiologicsTM, San Diego, CA) were grown in Medium 200
(Cascade BiologicsTM) with low serum growth supple-
ment – LSGS (Cascade BiologicsTM), 7 mmol/L homocy-
steine (DL-Homocysteine, Sigma Biochemicals, Dreisen-
hoffen, Germany), 0.1 ng/mL tumor necrosis factor-al-
pha (TNF-a; Sigma, St. Louis, Missouri, USA) and glu-
cose (Merck, Darmstadt, Germany) in a range of concen-
tration (5.5, 8.0, 12.0 and 16.5 mmol/L). HAEC were cul-
tivated at 37°C and 5% CO2 and passaged once or twice
per week. For experiment purpose, HAEC at passages
5–10 were used.
Drug treatment
Insulin (Actrapid Penfil 100 UI/mL, 3.5 mg/mL) was
kindly supplied by Novo Nordisk A/S (Bagsvaerd, Den-
mark). Used concentration of 1 mUI/mL is in the range
of therapeutic plasma concentrations in diabetic pati-
ents. The influence of insulin on CAMs expression was
analyzed in combination with each glucose concentra-
tion. Cells grown in corresponding (8.0, 12.0, 16.5
mmol/L) glucose concentrations and in physiological glu-
cose concentration (5.5 mmol/L) were used as controls.
Measurement of adhesion molecules expression
by flow-cytometry
After incubation with different concentration of glu-
cose and insulin the HAECs were washed twice with
PBS, incubated with fluorescent label-marked monoclo-
nal antibodies (R-phycoerythrin, R-PE, conjugated mou-
se anti-human monoclonal antibody) anti E-selectin, anti-
-ICAM-1 and anti-VCAM-1 (B.D. Pharmigen, San Diego)
for 20 min at 4°C. After washing with PBS, percent of
positive cells (mean fluorescence intensity – MFI wasn’t
analyzed) were analyzed on a flow-cytometer (FACS Ca-
libur, BD). A software system CELLQuest was used for
data acquisition and analysis. Data for minimum of 5x103
cells were collected and results expressed as a percentage
of fluorescent cells for each marker.
Statistical analysis
Statistical analysis was performed by one-way analy-
sis of variance (ANOVA) followed by the Student-New-
man-Keuls test. Differences were considered to be statis-
tically significant at p<0.05. Results are expressed as the
mean±SEM (standard error mean).
Results
Human aortic endothelial cells incubated in a me-
dium with physiological concentration of glucose (5.5
mmol/L) showed detectable (around 18.12%) expression
of E-selectin. The presence of moderate higher glucose
concentration (8.0 mmol/L) enlarged E-selectin expres-
sion (compared to control, by 2-fold), but this did not
reach statistical significance. Interestingly, incubation of
HAECs in a medium with higher glucose concentration
(12.0 and 16.5 mmol/L), expression of E-selectin de-
creased (compared to control, by 23% and by 88%, re-
spectively). The expression of ICAM-1 on HAECs at 5.5
mmol/L glucose was detectable (around 39.64%). Higher
concentrations of glucose (8.0 and 12.0 mmol/L) showed
T. Ba~un et al.: Insulin Administration Changes Expression of Adhesion Molecules, Coll. Antropol. 34 (2010) 3: 911–915
912
mild changes in ICAM-1 expression (increased for 47%
and for 64%, respectively), whereas incubation in 16.5
mmol/L glucose resulted in a substantial decrease (12%).
As presented in Figure 1, 5.06% of HAECs expressed
VCAM-1 after incubation in medium with 5.5 mmol/L
glucose. Incubation of cells with higher glucose concen-
trations (8.0 mmol/L and 12.0 mmol/L) enlarged VCAM-
-1 expression (compared to control, by 3-fold and by 41%,
respectively). In contrast, 16.5 mmol/L glucose resulted
in decreased VCAM-1 expression (43%).
Moreover, we have investigated the effects of insulin
on the CAM expression at HAECs incubated in medium
with various concentrations of glucose. Insulin was ad-
ded at 1 mIU/mL to mimic the concentrations used in di-
abetic patients. The data for CAM expression in the ab-
sence of insulin are used as a control. As shown in Figure
2, the addition of insulin was not changed CAMs expres-
sion on HAECs incubated in 5.5 mmol/L glucose. Inter-
estingly, at moderate higher glucose levels, 8.0 mmol/L,
the addition of insulin decreased (29%) E-selectin expres-
sion. Addition of insulin to the medium with mild hyper-
glycaemia (12.0 mmol/L) resulted in significantly (p=0.037)
decreased of E-selectin expression (27%). At 16.5 mmol/L
glucose, expression was moderate increased (9%) (Figure
2a). The effect of insulin on ICAM-1 expression were
modest (Figure 2b). The addition of insulin resulted in a
reduction in VCAM-1 expression on HAECs incubated at
8.0 mmol/L glucose (33%) and increased expression at
12.0 mmol/L and 16.5 mmol/L glucose (compared to con-
trol, by 23% and by 78%, respectively).
Discussion and Conclusion
In the present investigation we used an in vitro model
to study effects of elevated glucose concentration and in-
sulin administration on cell adhesion molecules (CAMs)
expression on the surface of human aortic endothelial
cells (HAEC). As shown in Figure 1, HAEC incubated in
a medium with physiological concentration of glucose
(5.5 mmol/L), express investigated adhesion molecules,
E-selectin (18.12%), ICAM-1 (39.64%), and VCAM-1
(5.06%) in detectable amounts. Our results show similar-
ity to the data reported by Kanda et al.25 and Maurus et
al.33 although in our study the CAMs expression was rel-
atively modest. The cause could be due short time of
cells’ exposition to elevated glucose (4 hours) and rela-
tively low concentration of added TNF-a. Namely, we ob-
served that without the addition of TNF-a and at 0.01
ng/mL of TNF-a in a physiological glucose concentration
and in conditions of hyperglycaemia, exposed cells did
not increase expression of adhesion molecules (data not
shown). To arouse the CAMs expression we used the low-
est effective concentration of TNF-a (0.1 ng/mL) in order
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Fig. 1. Effect of high glucose concentrations on cell adhesion
molecules expression on HAEC. Glucose concentration of 5.5
mmol/L was used as a control. After 4h incubation with various
glucose concentrations (5.5, 8.0, 12.0, and 16.5 mmol/L, respec-
tively) the expression of E-selectin, ICAM-1 and VCAM-1 was
measured by flow-cytometry. Data represent the mean±SEM
(standard error mean) of four independent experiments.
Fig. 2. Effect of high glucose concentrations and insulin (1
mUI/mL) administration on expression of adhesion molecules
E-selectin (a), ICAM-1 (b) and VCAM-1 (c) on HAEC. Glucose
concentrations of 5.5, 8.0, 12.0, and 16.5 mmol/L, respectively,
are used as controls. After 4 h incubation with various glucose
concentrations and insulin the expression of adhesion molecules
was measured by flow-cytometry. Data represent the mean of three
independent experiments. * p=0.037, for glucose 12.0 mmol/L vs.
glucose 12.0 mmol/L with insulin (Student-N-K test was used to
elevate the differences in the control vs. insulin group).
to exclude effects of cytokines’ activity on CAMs expres-
sion.
The presence of moderately elevated glucose concen-
tration (8.0 mmol/L) enlarged E-selectin expression, com-
pared to control, by 2-fold, but this did not reach statisti-
cal significance (Figure 1). In comparison to control, the
same glucose concentration caused mild changes in ICAM-
-1 expression (increased for 47%) and significantly en-
hanced VCAM-1 expression by 3-fold. Obtained results
support the hypothesis that increased expression of CAMs
is an early response of endothelial cells to moderate
hyperglycaemia17 and it is possible that CAMs are the
most sensitive indicator of early vascular dysfunction26.
As shown in Figure 1, incubation of HAEC in medium
with 12.0 mmol/L glucose, resulted in increased ICAM-1
(for 64%) and VCAM-1 (for 41%), whereas expression of
E-selectin was slightly decreased (for 12%). The same ef-
fect was previously observed in HUVEC cultured in me-
dium with similar glucose concentration29. Glucose in
concentration of 16.5 mmol/L diminished expression of
E-selectin for 88%, and VCAM-1 for 43%, as already
shown in our recent study27. The main cause could be in
cytotoxicity of glucose at this concentration. The cyto-
toxicity of glucose was already described in HUVEC after
treatment with 22.0 mmol/L glucose29. However, without
performing in vivo experiments it is not clear whether
the effect of high glucose concentration is direct or indi-
rect.
Results of our study also showed that the induction of
adhesion molecules can reflect direct effects of glucose on
endothelial cells in culture. Observed induction of ex-
pression of all three types of adhesion molecules on
HAEC in vitro after short-term exposure is in good corre-
spondence to the results of previous studies which sho-
wed that hyperglycaemia increases circulating endothe-
lial adhesion molecules in type 2 of diabetic patients
24,34,35. Moreover, increased plasma concentrations of the-
se adhesion molecules were associated with insulin con-
centrations and insulin resistance36.
Furthermore, we have investigated the effects of insu-
lin on the CAMs expression at HAEC incubated in me-
dium with various concentrations of glucose. Insulin was
added at 1 mIU/mL to mimic the concentrations used in
diabetic patients. The data for CAMs expression in the
absence of insulin are used as a control. As shown in Fig-
ure 2, the addition of insulin did not change CAMs ex-
pression on HAEC incubated in 5.5 mmol/L glucose. This
result indicates that insulin does not contribute to the
development of inflammation in vascular wall and ulti-
mately to the development of atherogenesis through ex-
pression CAMs on the surface of endothelial cells.
The addition of insulin resulted in decreased CAMs
expression at moderately higher glucose levels (8.0
mmol/L). Addition of insulin to the medium with mild
hyperglycaemia (12.0 mmol/L) resulted in a significant
(p=0.037) decrease of E-selectin expression (27%), while
expression of ICAM-1 and VCAM-1 was slightly enhan-
ced, for 4% and for 23%, respectively (Figure 2). At 16.5
mmol/L glucose, the effects of insulin on expression of
E-selectin and ICAM-1 were modest (Figure 2a and b).
The addition of insulin resulted in a reduction in
VCAM-1 expression on HAECs incubated at 8.0 mmol/L
glucose (33%) and increased expression at 12.0 mmol/L
and 16.5 mmol/L glucose (compared to control, by 23%
and by 78%, respectively).
Reduction of expression of E-selectin on HAEC in vi-
tro after short-term exposure to glucose, which was fou-
nd in this study, could contribute to elucidation of the re-
sults obtained in clinical studies which showed that
insulin administration leads to a sustained decrease in
sE-selectin concentration in patients with type 2 dia-
betes26. In clinical settings it is not clear yet whether the
effect of insulin is direct or indirect via the reduction of
glycaemia. With the help of in vitro model used in this
study, it is possible to eliminate indirect effects of insulin.
Indeed, we have shown that insulin has direct effect on
the expression of proinflammatory adhesion molecule
E-selectin. This finding supports the use of sE-selectin as
a marker of endothelial activation, induced by hypergly-
caemia26.
We demonstrate that the short-term effect of insulin
administration in the mild hyperglycaemia condition re-
duces the expression of the proinflammatory adhesion
molecule E-selectin, which could contribute to the slow-
ing down of the development of macrovascular complica-
tions in diabetic patients. However, we cannot exclude a
possibility that a long-term administration of insulin
may result in significant changes in CAMs expression of
endothelial cells. Furthermore, some of the insulin’s in
vivo effects could be indirect through better regulation of
glycaemia.
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PRIMJENA INZULINA U BLAGOJ HIPERGLIKEMIJI MIJENJA EKSPRESIJU UPALNIH
ADHEZIJSKIH MOLEKULA NA HUMANIM AORTALNIM ENDOTELNIM STANICAMA
S A @ E T A K
Poja~ana ekspresija stani~nih adhezijskih molekula (engl. Cell Adhesion Molecules, CAM) na povr{ini endotelnih
stanica je jedan od prvih koraka u endotelnoj disfunkciji uzrokovanoj povi{enom koncentracijom glukoze u dijabeti~ara.
Ispitivan je utjecaj primjene inzulina u uvjetima povi{ene koncentracije glukoze na ekspresiju E-selektina, adhezijske
molekule `ilne stijenke-1 (engl. Vascular Adhesion Molecule-1, VCAM-1) te me|estani~ne adhezijske molekule-1 (engl.
Intercellular Adhesion Molecule-1, ICAM-1) na humanim aortalnim endotelnim stanicama (engl. Human Aortic Endo-
thelial Cells, HAEC). Stanice su kultivirane 4 h u mediju s dodatkom homocisteina (7 mM) i razli~itim koncentracijama
glukoze (5,5; 8,0; 12,0 i 16,5 mM) s i bez dodatka inzulina (1 mIU/mL). Ekspresija CAMs analizirana je proto~nom
citometrijom uz primjenu monoklonskih protutijela. Kontrole su bile CAM eksprimirane u mediju s odgovaraju}om
koncentracijom glukoze. Dobiveni rezultati ukazuju da kratko vrijeme izlaganja HAEC blago povi{enoj koncentraciji
glukoze dovodi do pove}anja ekspresije E-selektina (2 puta), VCAM-1 (3 puta) i ICAM-1 (47%). Istovremeno, HAEC
izlo`ene 12 mM glukoze smanjuju ekspresiju E-selektina, a pove}avaju ICAM-1 (za 64%) i VCAM-1 (41%). 16,5 mM
glukoze smanjuje ekspresiju svih ispitivanih adhezijskih molekula. Dodatak inzulina nije mijenjao ekspresiju CAM u
mediju s 5,5 mM glukoze. U uvjetima povi{ene koncentracije glukoze (12 mM), dodatak inzulina zna~ajno smanjuje
E-selektin (27%) i pove}ava ekspresiju VCAM-1 (23%). Mo`e se zaklju~iti, blago povi{ena koncentracija glukoze pove-
}ava ekspresiju stani~nih adhezijskih molekula na HAEC. Dodatak inzulina u umjerenu hiperglikemiju reducira eks-
presiju proupalne adhezijske molekule E-selektin {to mo`da doprinosi usporavanju napredovanja makrovaskularnih
komplikacija u dijabeti~ara.
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